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Rediscovery of cold-activated brown adipose tissue
(BAT) in humans has boosted research interest in
identifying BAT activators for metabolic benefits. Of
particular interest are cytokines capable of fat
browning. Irisin, derived from FNDC5, is an exer-
cise-induced myokine that drives brown-fat-like
thermogenesis in murine white fat. Here we explored
whether cold exposure is an afferent signal for irisin
secretion in humans and compared it with FGF21,
a brown adipokine in rodents. Cold exposure
increased circulating irisin and FGF21. We found an
induction of irisin secretion proportional to shivering
intensity, in magnitude similar to exercise-stimulated
secretion. FNDC5 and/or FGF21 treatment upregu-
lated human adipocyte brown fat gene/protein
expression and thermogenesis in a depot-specific
manner. These results suggest exercise-induced
irisin secretion could have evolved from shivering-
related muscle contraction, serving to augment
brown fat thermogenesis in concert with FGF21.
Irisin-mediated muscle-adipose crosstalk may re-
present a thermogenic, cold-activated endocrine
axis that is exploitable in obesity therapeutics devel-
opment.
INTRODUCTION
Cold-induced thermogenesis (CIT) is the increase in heat pro-
duction in response to acute ambient temperature reduction. It
comprises nonshivering thermogenesis (NST) and shivering
thermogenesis (ST). In rodents, the chief tissue mediating NST
is brown adipose tissue (BAT), which releases heat through the
action of uncoupling protein 1 (UCP1) (Cannon and Nedergaard,
2004). Heat demand not met by NST recruits ST, thereby gener-
ating heat from muscle contractions. Long-term cold exposure
reduces shivering, conceivably a result of NST enhancement
from cold acclimatization (Davis, 1961). In humans, the rediscov-302 Cell Metabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Inery of cold-activated BAT suggests a possible regulatory role of
BAT in NST (Cypess et al., 2009; Saito et al., 2009; van Marken
Lichtenbelt et al., 2009; Virtanen et al., 2009). However, the phys-
iologic cues orchestrating NST and ST recruitment are unclear.
While adequate shelter and clothing in modern society have
minimized the hazards of cold temperatures, the obesity
epidemic has reignited interest into exploring whether harness-
ing BAT may benefit weight control (Yoneshiro et al., 2013).
Activated BAT may contribute up to 20% of CIT following mild
cold exposure (Chen et al., 2013), representing a proportion of
total energy expenditure (EE) sufficient to impact long-term
energy balance. Identification of BAT endocrine activators may
open new directions in obesity therapeutics development (Lee
et al., 2013b).
Irisin is an exercise-induced myokine that is secreted into the
circulation following proteolytic cleavage from its cellular form,
fibronectin-type III domain-containing 5 (FNDC5) (Bostro¨m
et al., 2012). It reverses diet-induced obesity and diabetes by
stimulating thermogenesis in rodents through increasing brown
adipocyte-like cell abundance (brite [Petrovic et al., 2010]/beige
[Wu et al., 2012] adipocytes) within white fat. As it appears par-
adoxical that exercise should increase secretion of a thermo-
genic hormone, it has been hypothesized that the mechanism
evolved from shivering-related muscle contraction to augment
NST through BAT expansion (Bostro¨m et al., 2012).
In this study, we tested this hypothesis by investigating the
impact of cold exposure in healthy adults on irisin secretion
and compared its excursion with the sympatho-thyroid-adrenal
axes, principal regulators of CIT (Celi et al., 2010), as well as
fibroblast growth factor 21 (FGF21), a recently identified brown
adipokine that predicts NST response in humans (Lee et al.,
2013a, 2013c). Finally, we examined in vitro the bioenergetic
profiles of FNDC5- and FGF21-treated human adipocytes to
determine their thermogenic significance.
RESULTS AND DISCUSSION
Irisin Detection in Human Serum
Circulating irisin, cleaved from FNDC5, is heavily glycosylated,
and multiple bands are visible on serum immunoblot against
anti-FNDC5 antibody (Bostro¨m et al., 2012). Because of the
recent controversy over the circulating form of irisin (Erickson,c.
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Figure 1. Validation of Immunoblot-
Detected Irisin by Mass Spectrometry
(A) Immunoblot of paired serum samples following
albumin/immunoglobulin depletion against anti-
FNDC5 antibody revealed multiple distinct bands
(a–f). PNGase treatment reduced size of band e
(32 kDa) to band f (24 kDa).
(B) Shown is the amino acid sequence of full-length
FNDC5 with the secreted irisin segment under-
lined. Mass spectrometry analysis of all bands (a–f)
identified a specific peptide (in red), unique to irisin,
only in band e and band f, with molecular weights
matching those of glycosylated and deglycosy-
lated irisin, respectively.
(C) Shown are representative immunoblots of
serum irisin for fold change quantification from two
subjects during cold exposure, maximal exercise,
and submaximal exercise. Subject 1 shivered
during cold exposure, while subject 2 did not.
Accordingly, deglycosylated irisin band (24 kDa)
was stronger at the end of cold exposure only in
subject 1. In contrast, irisin band was stronger after
submaximal exercise in both subjects. Full-sized
blots are shown in Figure S1.
(D–F) Graphical representation of serum irisin fold
changes during cold exposure, maximal, and
submaximal exercise tests, respectively, of all ten subjects. ‘‘Post’’ indicates the average band intensity of irisin extracted from themid and final blood samples of
each clinical test. Similar results were obtained when analysis was conducted comparing irisin band intensity between baseline and final sample alone. Irisin level
rose significantly following sub-maximal exercise (F) and trended higher (p = 0.07) after maximal exercise (E). Irisin levels increased only in the seven subjects who
shivered (closed circles, D), but not those who did not (open circles, D).
(G) Neutralization of anti-FNDC5 antibody by FNDC5 recombinant protein. FNDC5 antibodymixture in increasing ratio resulted in quenching of western signal in a
dose-dependent manner by excess FNDC5 recombinant protein. *p < 0.05. Data are presented as mean ± SD.
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reactive bands detectable in human serum by mass spectrom-
etry (MS).
Consistent with previous reports, immunoblot of albumin/
immunoglobulin-depleted serum revealed multiple bands reac-
tive to anti-FNDC5 antibody. Deglycosylation reduced the size
of a 32 kDa band to 24 kDa, corresponding to reportedmolecular
weights (MWs) of glycosylated and deglycosylated irisin, respec-
tively (Figure 1A) (Bostro¨m et al., 2012; Schumacher et al., 2013).
MS analysis identified a unique peptide, mapped to the known
sequence of irisin, only within the 32 kDa and 24 kDa bands
(Figure 1B). These results thus validated immunoblot identifica-
tion of circulating irisin in humans. To further ascertain specificity
of antibody used, we also demonstrated successful quenching
of irisin signal by excess recombinant protein (Figure 1G).
Exercise Increases Serum Irisin Levels in Humans
To understand the interrelationships between exercise, cold
exposure, and irisin, we compared irisin secretion in ten healthy
adults (four females, 27 ± 5 years old, body mass index [BMI]
22 ± 2 kg/m2, body fat (BF) 24% ± 9%) following graded, step-
wise cold exposure (27C–12C, see Figure S1 available online)
with two forms of standard exercise tests: exercise on cycloerg-
ometer to maximal capacity (VO2max) and submaximal exercise
test at 40% VO2max for 1 hr.
Serum irisin levels trended higher (p = 0.07) after maximal
exercise (Figures 1C and 1E). After 60 min of submaximal exer-
cise, irisin levels rose by 3.1- ± 2.8-fold (p < 0.05) (Figures 1C
and 1F). These results thus replicated the known stimulatory
effect of exercise on irisin secretion (Bostro¨m et al., 2012; HuhCell Met al., 2012). The greater irisin increase during submaximal
exercise compared to maximal exercise suggests endurance
exercise maybe a more potent stimulus of irisin secretion,
consistent with the finding of higher FNDC5 expression in oxida-
tive versus glycolytic muscle fibers (Wrann et al., 2013).
Shivering Is an Afferent Signal of Irisin Secretion
We next determined the impact of cold temperature on irisin
changes. Upon cold exposure, skin temperature decreased in
all subjects (p < 0.0001) while core temperature was preserved
(Table 1; Figure 2A). Arm-to-hand, skin-to-core, and supracla-
vicular-to-chest temperature gradients increased by 13% ±
18% (p = 0.01), 45% ± 15% (p < 0.0001), and 4% ± 3% (p <
0.0001), signifying vasoconstrictive, insulative, and thermo-
genic responses, respectively. EE rose by 48% ± 37% (p <
0.01), representing CIT response (Figure 2A). Seven subjects
reported shivering, and shivering activity, quantified by surface
electromyography (EMG), increased during cold exposure (p <
0.01) (Table 1). The increase in EMG activity was 88% ± 80% in
individuals who shivered and 13% ± 9%, among those who did
not (p < 0.05). Our cooling protocol thus elicited the full spec-
trum of CIT response, allowing the interrogation of irisin-CIT in-
terrelationships. Irisin changes correlated the strongest with
shivering among all CIT components (Table S1). Circulating iri-
sin rose in the seven subjects who shivered (Figures 1C and
1D), and changes in irisin levels correlated positively with shiv-
ering activity (r = 0.91, p < 0.001) (Figure 2B). To ensure
accuracy of our quantification, we also demonstrated con-
cordant irisin changes measured with a commercially available
irisin enzyme-linked immunosorbant assay (Figures 2E andetabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Inc. 303
Table 1. Physiologic Changes during Cold Exposure and Hormonal Profile during Cold Exposure and Exercise Tests in Ten Subjects
Physiologic Variables
Body Temperature (C) 27C 18C 16C 14C 12C Trend p Value
Core 36.9 ± 0.2 36.9 ± 0.2 36.9 ± 0.2 36.9 ± 0.2 36.9 ± 0.2 0.65
Skin 32.1 ± 0.5 31.7 ± 0.7 31.1 ± 0.8 30.7 ± 0.9 30.0 ± 1.0 <0.0001
Gradient, core-to-skin 4.5 ± 0.8 4.8 ± 0.9 5.4 ± 1.1 5.9 ± 1.2 6.5 ± 1.2 <0.0001
Gradient, arm-to-hand 6.7 ± 1.7 7.1 ± 1.8 7.4 ± 1.8 7.2 ± 1.8 7.3 ± 1.5 0.01
Gradient, supraclavicular-to-chest 1.04 ± 0.03 1.05 ± 0.03 1.06 ± 0.04 1.07 ± 0.05 1.09 ± 0.06 <0.0001
Resting EE (kcal/day) 1,488 ± 196 1,731 ± 337 1,926 ± 673 2,100 ± 785 2,235 ± 738 0.007
Respiratory quotient 0.78 ± 0.03 0.85 ± 0.07 0.79 ± 0.07 0.77 ± 0.07 0.79 ± 0.08 0.001
Surface electromyography (3106 RMS) 2.5 ± 5.7 3.1 ± 2.1 4.0 ± 4.0 4.7 ± 3.6 4.9 ± 3.3 0.044
Hormonal Variables
Cold Exposure Maximal Exercise Submaximal Exercise
Baseline End Baseline End Baseline End
Epinephrine (pg/ml) 38 ± 25 110 ± 73a 237 ± 418 300 ± 316 180 ± 406 311 ± 558 a
Norepinephrine (pg/ml) 658 ± 306 1,101 ± 449a 727 ± 264 1,568 ± 541a 714 ± 173 974 ± 209a
Glucose (mg/dL) 84 ± 3 86 ± 2 91 ± 6 117 ± 22a 87 ± 4 90 ± 10
Insulin (U/L) 4.2 ± 1.1 5.3 ± 1.1 6.8 ± 3.6 21.4 ± 22.6a 6.6 ± 3.5 7.9 ± 5.2
HOMA IR 1.0 ± 0.8 1.3 ± 0.8 1.5 ± 0.9 6.5 ± 6.7a 1.4 ± 0.8 1.8 ± 1.2
NEFA (mEq/L) 0.55 ± 0.07 0.57 ± 0.07 0.49 ± 0.19 0.45 ± 0.19 0.47 ± 0.23 0.65 ± 0.22a
TSH (mIU/L) 1.9 ± 0.3 2.1 ± 0.3 2.1 ± 0.7 2.5 ± 0.9a 1.9 ± 0.6 1.9 ± 0.7
Free T4 (ng/dL) 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1
Free T3 (pg/dL) 320 ± 17 346 ± 13 299 ± 43 296 ± 47 312 ± 45 311 ± 41
Total T3 (ng/dL) 134 ± 22 139 ± 17 115 ± 29 114 ± 16 121 ± 23 117 ± 17
ACTH (pg/ml) 17 ± 9 19 ± 6 27 ± 16 156 ± 133a 19 ± 10 37 ± 31a
Cortisol (mg/dL) 12 ± 3 15 ± 5 16 ± 5 18 ± 6 14 ± 4 16 ± 5
FGF21 (pg/ml) 129 ± 76 98 ± 90 135 ± 80 102 ± 97 119 ± 79 97 ± 85
Data are presented as mean ± SD.
ap < 0.05 compared to baseline.
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(Wen et al., 2013).
As exercise is the only known activator of irisin secretion, we
compared cold- and exercise-induced irisin changes. The in-
crement in irisin was similar during the two tests (Figure 2C).
However, the increase in EE was significantly greater during
maximal exercise, compared to cold exposure (9.8- ± 2.4-fold
versus 1.5- ± 0.4-fold, p < 0.0001). The dissociation between
irisin and EE responses suggests additional cold-specific sig-
nals, unrelated to muscle contraction, potentiating irisin secre-
tion during shivering. As NST, mediated by BAT (Cannon and
Nedergaard, 2004) and muscle (Bal et al., 2012), is activated
with ST, we explored whether FGF21, a brown adipokine in
rodents (Chartoumpekis et al., 2011; Hondares et al., 2011)
and humans (Lee et al., 2013c), relates to shivering-induced irisin
secretion.
Distinct Involvement of Irisin and FGF21 during
Shivering and Nonshivering Thermogenesis
In agreement with known diurnal reduction in circulating FGF21
levels in humans (Yu et al., 2011), FGF21 concentration trended
lower during all three tests (cold exposure and exercise tests)
undertaken between 8:00 and 10:00 a.m. (Table 1). Greater
FGF21 reduction was associated with more intense shivering,304 Cell Metabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Inalthough it did not reach significance (p = 0.08) (Figure 2D).
We interpret a greater reduction in FGF21 levels as lesser
FGF21 secretion, indicating a lower NST response (Lee et al.,
2013a) and leading to ST recruitment for additional heat genera-
tion. This is corroborated by a positive correlation observed
between supraclavicular skin temperature (i.e., an index of BAT
activity [Lee et al., 2011]) and FGF21 changes (Table S1;
Figure 2F). To further substantiate our interpretation of cold-
induced FGF21 secretion, we undertook two additional ex-
periments in separate groups of subjects to characterize (1)
relationships between BAT and FGF21 and (2) temperature de-
pendency of FGF21 diurnal rhythm.
First, to elucidate whether BAT is a significant source of cold-
augmented FGF21 secretion, we profiled FGF21 excursions in
five men (21 ± 2 years old; BMI, 22 ± 1 kg/m2; BF, 21% ± 2%)
stratified to BAT status during 5 hr of either mildly cold, non-
shivering condition (19C) versus thermoneutrality (24C) (Fig-
ures 2G and 2H). FGF21 diurnal reduction was blunted at 19C
in the group as a whole by 23% ± 17% (p < 0.05). However,
the blunting effect was markedly greater in BAT-positive,
compared to BAT-negative, subjects (Figures 2K and 2L), trans-
lating to a total FGF21 output more than 6-fold higher in BAT-
positive individuals. Since the subjects were of similar age and
leanness and differed only by BAT status, these associativec.
Figure 2. Relationship between Irisin, FGF21, BAT, and Temperature
Cold exposure resulted in reduction in skin temperature (open circles, A), accompanied by a rise in energy expenditure (EE) (closed circles), both reaching
significance from 16C to 12C. Panels (B) (by immunoblot) and (E) (by ELISA) show positive associations between irisin and EMG fold changes during cold
exposure. Panel (C) compares irisin and EE fold changes during cold exposure with maximal exercise test. Changes in FGF21 levels correlated negatively with
shivering (D) but positively with thermogenic response (TR; difference between supraclavicular skin and chest TC) (F). In (G) and (H), representative PET-CT
images of BAT-positive (n = 3) and -negative (n = 2) individuals are shown, respectively (BAT in red). FGF21 diurnal reduction was more markedly blunted in BAT-
positive (solid lines) compared to BAT-negative (dashed lines) individuals at 19C (L) versus 24C (K). Panels (I) and (J) compared FGF21 changes (n = 5)measured
between 8 and 10 a.m. at either warm (27C) or shivering (12C) conditions. FGF21 reduction was significantly blunted in the cold. *p < 0.05 compared to warm
condition; #p < 0.001 compared to cold exposure. Data are presented as mean ± SD.
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in humans.
Second, to verify that FGF21 diurnal rhythm is indeed temper-
ature sensitive, we measured FGF21 changes in another five
men (26 ± 6 years old; BMI, 23 ± 2 kg/m2; BF, 19% ± 3%) under
the same shivering-inducing cold exposure employed in the
main study but on a separate day exposed the same subjects
to a warm temperature (27), during which FGF21 wasmeasured
at matching time points. Cold exposure blunted FGF21 diurnal
reduction by 28% ± 23% (p = 0.02) (Figures 2I and 2J). Pooling
the results in these five subjects with the ten subjects originally
studied, we observed a significant positive association between
FGF21 diurnal reduction and shivering intensity (r = 0.53, p <
0.05).
Collectively, our findings indicate concerted stimulated secre-
tion of FGF21 and irisin during NST and ST, respectively. In other
words, shivering stimulates irisin secretion in a FGF21-primed
milieu, through a mechanism mimicked by muscle contraction
during exercise, which offers a plausible reconciliation for theCell Mparadox of why exercise, an energy-dissipating process, should
stimulate the release of a thermogenic hormone.
FNDC5/FGF21 Induce Expression of Beige Gene
Transcriptome in Human Neck Adipocytes
These results led us to probe the biological significance under-
lying enhanced irisin and FGF21 secretion during cold exposure.
We hypothesize the two hormones are cold activated to boost
whole-body thermogenic capacity by switching on brown-fat-
like program in white fat. We thus examined in vitro the bio-
energetic profiles of FNDC5- and FGF21-treated primary human
adipocytes established from neck fat biopsies, a location known
to be enriched with beige adipocytes.
While stimulated beige adipocytes manifest thermogenic
capacity similar to that of classic brown adipocytes, they are
characterized by a distinct gene signature (Cypess et al., 2013;
Jespersen et al., 2013; Sharp et al., 2012; Wu et al., 2012). We
therefore first determined the impact of FNDC5 and/or FGF21
treatment on classic brown and beige gene expression in humanetabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Inc. 305
Figure 3. Effects of FNDC5 and/or FGF21 Treatment on Gene/Protein Expression and Bioenergenetics of Neck Adipocytes
(A) Effects of FGF21 and/or FNDC5 treatment on BAT/beige/white gene markers in neck adipocytes (n = 6). UCP1 protein was absent in PBS-treated adipocytes
but was detected following FGF21 and/or FNDC5 treatment (B). UCP1 protein was highest in adipocytes treated with dual FGF21/FNDC5. Neck adipocytes
displayedmultilobulated lipid droplets (403), similar before and after treatment (C, F+F = FNDC5+FGF21 treatment). Expression of FABP4, a general adipogenic
gene, was not different following treatment (D). Induction of UCP1 was accompanied by upregulation of basal (F), oligomycin-insensitive, maximal uncoupled (G),
and norepinephrine-induced (E) oxygen consumption, most robust in dual FGF21/FNDC5-treated adipocytes (n = 4). (H) Infrared thermographic images of
adipocytes in microplates treated with PBS, FGF21, and/or FNDC5 (n = 4). The temperature scale showed color representation of temperature variation. Heat
production was increased in the basal state by FNDC5 but not FGF21. Addition of norepinephrine (NE) increased heat production in increasing magnitude in
FGF21-, FNDC5-, and dual FGF21/FNDC5-treated adipocytes. These results are displayed in graphical format in (I). *p < 0.05 compared to PBS; #p < 0.05
compared to FNDC5- or FGF21-treated adipocytes; cp < 0.05 compared to FGF21-treated adipocytes. Data are presented as mean ± SD.
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general BAT and beige gene expression without altering those
belonging to the classic brown fat lineage (Figure 3A). UCP1
protein, absent in untreated adipocytes, became strongly
expressed following FNDC5 and/or FGF21 treatment (Figure 3B).
Pre- and posttreatment adipocytes displayed similar mor-
phology, lipid accumulation, and general adipogenic gene
expression (Figures 3C and 3D), indicating thermogenic gene
upregulation was not a result of more efficient differentiation.
Bioenergetic Activation of Human Neck Adipocytes by
FNDC5/FGF21
We next investigated the functional impact of FNDC5 and FGF21
on adipocyte thermogenic function. We chose a treatment dura-306 Cell Metabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Intion of 6 days, as guided by previous studies reporting a reduc-
tion of shivering in cold acclimatized humans after 1 week (Davis,
1961). FNDC5 and/or FGF21 enhanced adipocyte basal oxygen
consumption rate (OCR) (Figure 3F), as measured using an
extracelluar fluid bioanalyzer. Pharmacological interrogation of
mitochondrial respiration revealed augmentation of both forms
of respiratory uncoupling (oligomycin-insensitive and maximal)
by FNDC5 and FGF21 treatment (Figure 3G). To mimic cold
exposure in vitro, wemeasured norepinephrine-induced thermo-
genesis. While untreated adipocytes did not respond to nor-
epinephrine, FNDC5 and FGF21 both induced a robust increase
in OCR upon norepinephrine exposure (Figure 3E) and thus
recapitulated the observed cold-induced hormonal response
in vivo. Combined FNDC5/FGF21 treatment produced greaterc.
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pocytes with irisin instead of FNDC5 resulted in a similar extent
of fat browning on gene, protein, and functional levels
(Figures S2A and S2C–S2E), consistent with previous findings
in murine fat cells (Wu et al., 2012), and suggests both FNDC5
and irisin in the circulation could be biologically active at adipose
tissue.
FNDC5/FGF21 Increases Human Neck Adipocyte Heat
Production
As the primary function of BAT is to generate heat, we next quan-
tified heat production from adipocytes directly by infrared ther-
mography (IRT) (Figure S2G). FNDC5 treatment enhanced
adipocyte heat production dose dependently (Figures 3H and
3I), which was further augmented by norepinephrine. In contrast,
FGF21 increased heat production only after norepinephrine
exposure. Additive effects were again observed following com-
bined FNDC5/FGF21 treatment.
Taken together, these in vitro experiments provide mecha-
nistic insight into our in vivo observations. It is conceivable that
shivering-stimulated irisin, in concert with FGF21, phenotypically
transforms white adipocytes to BAT-like cells to expand overall
thermogenic capacity. This heat-generating hormonal response
may confer an evolutionary advantage in the defense against
environmental hypothermic challenges by boosting the more
energy-efficient NST response over shivering.
Fat Depot-Specific Effects of FNDC5/FGF21
From a clinical perspective, a 2- to 3-fold increase in adipocyte
OCR following FNDC5/FGF21 treatment, if extrapolated to the
whole-body EE level, could be substantial. However, the in vivo
relevance is dependent on the generalizability of our findings to
other fat depots. We therefore repeated FNDC5/FGF21 experi-
ments in primary human subcutaneous and visceral adipocytes.
FNDC5/FGF21 enhanced BAT-like thermogenic program in
subcutaneous but not omental adipocytes, and the magnitude
of thermogenic activation was less compared to those observed
in neck adipocytes (Figures S3 and S2F). Beige gene expression
was either low (subcutaneous adipocytes) or absent (omental
adipocytes). In rodents, irisin treatment only increased UCP1 in
beige fat gene-expressing adipocytes (Wu et al., 2012). Lower
or absent beige gene expression in subcutaneous and omental
adipocytes may account for the modest or lack of response of
these adipocytes to FNDC5/FGF21.
Metabolic Significance and Clinical Implications
Although our sample size is relatively small, our results are
physiologically and clinically relevant. First, they uncover an
intriguing evolutionary interconnection between exercise and
shivering, juxtaposing at the muscle-fat interface through
cold-induced endocrine BAT activators. As irisin levels were
higher in shivering subjects, we hypothesize muscle to be the
main contributor to the observed irisin rise, although adipose-
derived irisin cannot be excluded (Roca-Rivada et al., 2013).
Second, while the sympathetic nervous system (SNS) is the
best-known mediator of CIT, recent evidence points to the ex-
istence of specific cold-induced neuroendocrine signals in ani-
mals, whose actions are highly fat specific, without undesirable
global SNS activation (Villarroya and Vidal-Puig, 2013). OurCell Mstudy provides evidence supporting similar fat browning capac-
ity of two of these cytokines, irisin and FGF21. Third, our irisin
detection validation clarifies recent concerns over specificity
of irisin immunoblotting (Erickson, 2013). Although the antibody
used recognizes a peptide present in FNDC5, which is theoret-
ically lost during irisin-specific proteolytic cleavage, it is
possible that shivering induces release of FNDC5 fragments
that harbor the antibody-reactive peptide. While the dynamics
of irisin secretion remain to be clarified in future studies, identi-
fication of the same peptide sequence shared by circulating iri-
sin (shown in our clinical study) and recombinant FNDC5/irisin
proteins used in our in vitro experiments offers renewed
perspective over controversy on the relevance of irisin in human
biology (Atherton and Phillips, 2013). Fourth, our finding of fat
depot-specific browning by FNDC5 suggests adipocyte brown-
ing potential may impact response to FNDC5/irisin and may
account for negative results utilizing solely subcutaneous adipo-
cytes (Raschke et al., 2013). Finally, long-term maintenance of
regular exercise is challenging, and natural human tendency
for thermal comfort limits cold exposure in contemporary soci-
ety. Irisin and FGF21 may represent endocrine mimics of these
thermogenic stimuli and are therefore potential therapeutic tar-
gets to attain weight control and to improve overall metabolic
profile.
EXPERIMENTAL PROCEDURES
Clinical Studies
Healthy volunteers provided written informed consent. The NIDDK-NIAMS
institutional review board approved the studies (http://clinicaltrials.gov,
NCT00521729 and NCT01730105). We conducted three sets of studies. (1)
Main Study consisted of three experiments: cold exposure, maximal, and
submaximal exercise tests; (2) PET-CT Study involved FGF21 profiling in
volunteers stratified to BAT status; and (3) Temperature Study determined
temperature dependence of FGF21 diurnal rhythm.
Main Study
These tests allowed comparison of hormone/substrate profiles during active
muscle contractions with cold-induced shivering. Volunteers were admitted
after an overnight fast (September 2012–March 2013) for each test, performed
at least 3 days apart.
Cold Exposure Test
Ten volunteers wearing hospital scrubs rested in beds in a room at 24C.
Two water-infused thermoblankets (Gaymar Medi Therm) were used to
adjust rapidly temperature exposure (Figure S1A). Thirty minutes of resting
EE measurement was obtained by indirect calorimetry when water
temperature was at 27C, after which it was cooled to 18C, then further
lowered by 2C every 3 min until 12C was reached. EE measurement
continued throughout this period, and the test concluded after 5 min at
12C. Shivering intensity was measured by surface electromyography (EMG)
(Trigno, DelSys Inc.).
Exercise Tests
Maximal exercise test was performed on a mechanically braked cycle ergom-
eter (Ergomedic 839E, Monark Exercise). A stepwise incremental exercise test
was performed to assess maximal aerobic capacity (VO2max) using breath-by-
breath analysis. For the submaximal exercise test, volunteers cycled for 1 hr at
an intensity of 40% of VO2max.
Laboratory Measurements
Three blood samples were obtained during each test for hormone/substrate
measurements: baseline, 5 min after the start of cooling or maximal exercise,
and at the conclusion of the test. For the submaximal exercise test, samples
were obtained at baseline, 30 min into, and at the end of the test. Serum irisin
wasmeasured bywestern blotting (Bostro¨m et al., 2012) and plasma FGF21 by
enzyme immunoabsorbant assays.etabolism 19, 302–309, February 4, 2014 ª2014 Elsevier Inc. 307
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Five subjects were studied after an overnight fast. They were exposed to either
24 hr of mild cold (19C) or thermoneutral temperature (24C). Blood samples
were obtained at 08:00, 09:00, 10:00, 12:00, and 13:00, corresponding to 0, 1,
2, 4, and 5 hr after exposure to testing temperature. FGF21 levels were
measured by same ELISA as in Main Study. At the end of 24 hr exposure to
19C, each subject received a 5 mCi dose of 18flurodeoxyglucose (FDG) at
08:00 and underwent PET-CT scanning.
Temperature Study
Five subjects underwent the same cold exposure study as those in Main
Study. Blood samples were obtained at baseline and at the end of the cold
exposure study for FGF21 measurements and correlation with shivering activ-
ity. On a separate day, subjects returned and were exposed to a constant
warm temperature at 27C for the same duration as the cold exposure testing
period. Blood samples were obtained at matching time points for FGF21 mea-
surements to directly compare with levels obtained during cold exposure.
In Vitro Studies
Adipocyte Culture
Thermogenic effects of FNDC5/FGF21 were tested on primary adipocytes
established from human cervical, subcutaneous, and omental fat, as previ-
ously described (Lee et al., 2013c).
Gene/Protein Expression and Thermogenesis
Standard techniques were used for RNA/protein extraction and analysis by
semiquantitative real-time PCR and immunoblotting. Cellular respiration was
measured by XF24-3 extracellular flux analyzer (Seahorse Bioscience). Heat
production was measured by IRT (FLIR Systems), as previously described
(Lee et al., 2013c).
Additional clinical/laboratory experimental details and PET-CT scanning
analytical methods are available in the Supplemental Information.
Statistical Analysis
Statistical analysis was performed using SPSS 20.0 (SPSS, Inc.). Data are
expressed as mean ± SD. Comparisons between results during graded cold
exposure (Main Study) and FGF21 time course (PET-CT Study) were per-
formed using repeated-measure ANOVA with Bonferroni’s correction. Paired
t test was used for comparison of measurements at 24C and 19C. Data
not normally distributed were log transformed before analysis but are pre-
sented in the text nontransformed. Pearson correlation coefficients were
used to examine linear relations between variables. Areas under the curve
were calculated using the trapezoidal rule. An a error of 0.05 was considered
the threshold for statistical significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one table, and three figures and can be found with this article at http://dx.
doi.org/10.1016/j.cmet.2013.12.017.
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